Clinical trial

LACunar Intervention (LACI-2) Trial-2

NCT03451591

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-01-08

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2018-01-08Date precision: day

Registry last updated2024-11-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cerebral Small Vessel Diseasesunresolved

Stroke, Lacunarunresolved

Interventions

Isosorbide Mononitrate XL (ISMN)DRUG

CilostazolDRUG · verified · RxNorm: cilostazol

ISMN XL and CilostazolDRUG

Neither ISMN nor cilostazolOTHER

Sponsors & collaborators

University of Edinburghlead sponsor

British Heart Foundationcollaborator

University of Nottinghamcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03451591 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.